Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Charcot-Marie-Tooth syndrome

P F Chance1, D Pleasure

  • 1Department of Pediatrics, University of Utah Medical Center, Salt Lake City.

Archives of Neurology
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Schwann Cell Apoptosis during Cell-Mediated Demyelination.

Annals of the New York Academy of Sciences·2017
Same author

The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.

Experimental brain research·2016
Same author

Non-recurrent SEPT9 duplications cause hereditary neuralgic amyotrophy.

Journal of medical genetics·2009
Same author

Immunologic characterization of oligodendroglia.

Neuroscience letters·2009
Same author

Mutations in 3 genes (MKS3, CC2D2A and RPGRIP1L) cause COACH syndrome (Joubert syndrome with congenital hepatic fibrosis).

Journal of medical genetics·2009
Same author

SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy.

Neurology·2009

Charcot-Marie-Tooth syndrome (CMT) is a genetic neuropathy. CMT1A, the most common form, involves duplication of the PMP-22 gene on chromosome 17, while HNPP involves deletion in the same region.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Charcot-Marie-Tooth syndrome (CMT) encompasses genetically determined peripheral neuropathies.
  • Specific CMT types, including CMT1A, CMT1B, CMTX, CMT1C, and CMT2, are linked to distinct chromosomal locations.
  • The most common form, CMT1A, is an autosomal dominant demyelinating disorder.

Purpose of the Study:

  • To investigate the genetic basis of Charcot-Marie-Tooth syndrome (CMT) and Hereditary Neuropathy with Liability to Pressure Palsies (HNPP).
  • To elucidate the molecular mechanisms underlying CMT1A and HNPP, focusing on the PMP-22 gene and chromosome 17.
  • To understand the relationship between gene dosage and disease phenotype in peripheral neuropathies.

Main Methods:

  • Genetic locus mapping to identify chromosomal locations of CMT subtypes.

Related Experiment Videos

  • Analysis of peripheral myelin protein-22 (PMP-22) gene mutations and copy number variations.
  • Comparative analysis of CMT1A (duplication) and HNPP (deletion) in the 17p11.2-12 region.

    • Main Results:

    • CMT1A is primarily caused by a tandem duplication in chromosome 17p11.2-12, leading to increased PMP-22 gene expression.
    • Less frequently, CMT1A results from missense mutations in the PMP-22 gene.
    • Hereditary Neuropathy with Liability to Pressure Palsies (HNPP) is associated with a deletion in the same 17p11.2-12 chromosomal segment.

    Conclusions:

    • The PMP-22 gene dosage is critical in determining the phenotype of demyelinating neuropathies.
    • Unequal crossing over during meiosis is the likely mechanism for the reciprocal duplication (CMT1A) and deletion (HNPP) events.
    • These findings highlight the importance of the 17p11.2-12 region in peripheral nerve development and function.